| 1/3/2013 | BKIG | Watson Pharmaceuticals readies for growth, new products, name change
|
| 9/27/2012 | BKCVIG | Fitch lowers Watson
|
| 9/27/2012 | BKCVIG | S&P rates Watson notes BBB
|
| 9/27/2012 | BKIG | Moody's: Watson notes Baa3
|
| 6/27/2012 | BKCVIG | Fitch rates Watson loan BBB
|
| 6/25/2012 | BK | Watson Pharmaceuticals gets $1.8 billion five-year loan to buy Actavis
|
| 5/23/2012 | BK | Watson Pharmaceuticals ups revolver to $750 million, modifies covenants
|
| 4/25/2012 | BKIG | Watson plans to fund €4.25 billion acquisition with term loan, notes
|
| 1/24/2012 | BK | Watson uses credit facility borrowings to fund Ascent acquisition
|
| 9/19/2011 | BK | Watson wraps $500 million revolving facility at Libor plus 125 bps
|
| 8/18/2009 | BKCV | Fitch affirms Watson
|
| 8/18/2009 | BK | Watson Pharmaceuticals to repay $100 million in term loan borrowings
|
| 8/18/2009 | BKCV | Moody's affirms Watson
|
| 7/7/2009 | BK | Watson amends to permit up to $500 million in general unsecured debt
|
| 6/18/2009 | BKCV | Fitch affirms Watson
|
| 6/17/2009 | BKCV | Moody's: Watson loans on review uncertain
|
| 6/17/2009 | BKBWCVSS | Watson may refinance convertibles to help fund Arrow acquisition
|
| 5/26/2009 | BKCV | Moody's: Watson outlook positive
|
| 2/25/2008 | BK | Watson Pharmaceuticals repays $75 million of bank debt
|
| 11/6/2006 | BK | Market Commentary: Freescale, RSC, Energy Transfer set talk; Greenwood cuts pricing; Per-Se softer on buyout news
|
| 9/21/2006 | BKBTCVHY | Moody's revises ratings for nine U.S. pharma companies
|
| 8/4/2006 | BKBTCVHY | Moody's cuts Watson Pharmaceutical convertibles to Ba2, rates loans Ba1
|
| 8/4/2006 | BKBTCVHY | S&P rates Watson Pharmaceuticals loan BBB-, lowers notes to BB+
|
| 7/17/2006 | BKBT | Watson Pharmaceuticals sets Wednesday launch for $1.15 billion credit facility
|
| 3/15/2006 | BKBTCV | Moody's may downgrade Watson
|
| 3/15/2006 | BKBT | Watson Pharmaceuticals outlines structure on $1.15 billion facility
|
| 3/13/2006 | BKBT | Watson Pharmaceuticals to get $1.15 billion in bank debt for Andrx purchase
|
| 3/7/2006 | BKBT | Watson Pharmaceuticals amends loan, allowing for stock repurchases
|
| 7/1/2004 | BKCV | Moody's affirms Watson
|
| 7/1/2004 | BKCV | S&P: Watson outlook negative
|
| 6/2/2003 | BK | Market Commentary: Qwest upsizes, Charter and Nextel firm in trading
|
| 3/5/2003 | BK | Shiloh Industries reduces bank debt by over $60 million
|
| 3/4/2003 | BK | Watson Pharmaceuticals gets commitment for $300 million revolver
|
